Article (Published version) (436 Kb) - 
Limited access to UNIGE
Highlights
Scientific Article
unige:89945 
 |
Update on multiple sclerosis treatments |
|
| Authors | ||
| Published in | Swiss Medical Weekly. 2014, vol. 144, w14012 | |
| Abstract | Relapsing-remitting multiple sclerosis (RRMS) management has dramatically changed over the past decade. New drugs have arrived on the market, allowing for more individualised treatment selection. However, this diversity has increased the complexity of RRMS patient follow-up. In this review, we provide summarised information about treatment efficacy, potential side-effects, follow-up recommendations, vaccinations, and pregnancy safety issues for all currently available disease modifying therapies and those awaiting approval. | |
| Keywords | Antibodies, Monoclonal, Humanized/therapeutic use — Crotonates/therapeutic use — Dimethyl Fumarate — Fingolimod Hydrochloride — Fumarates/therapeutic use — Humans — Immunoglobulin G/therapeutic use — Immunosuppressive Agents/administration & dosage/adverse effects/therapeutic use — Interferon-beta/therapeutic use — Multiple Sclerosis, Relapsing-Remitting/drug therapy — Natalizumab — Propylene Glycols/therapeutic use — Sphingosine/analogs & derivatives/therapeutic use — Toluidines/therapeutic use | |
| Identifiers | PMID: 25247669 | |
| Full text | ||
| Structures | ||
| Research group | Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843) | |
| Citation (ISO format) | BRIDEL, Claire, LALIVE D'EPINAY, Patrice. Update on multiple sclerosis treatments. In: Swiss Medical Weekly, 2014, vol. 144, p. w14012. doi: 10.4414/smw.2014.14012 https://archive-ouverte.unige.ch/unige:89945 |
317 hits 
0 download 
Contact an author
Update